Citurgia Biochemicals Ltd
Citurgia Biochemicals is engaged in manufactures citric acid, calcium carbonate and plasticizers. Citric acid is traditionally used in foods, soft drinks, confectionary and drugs. It is also used in chemicals, where it provides stable pH conditions for polyester and nylon. Acrylic print curing and cotton- resist printing.(Source : 201903 Annual Report Page No:62)
- Market Cap ₹ 1,615 Cr.
- Current Price ₹ 122
- High / Low ₹ 212 / 47.4
- Stock P/E
- Book Value ₹ -0.59
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 2.00
Pros
Cons
- Company has low interest coverage ratio.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.18 | 0.16 | 0.10 | 0.18 | 0.24 | 0.12 | 0.37 | 0.18 | 0.21 | 0.25 | 0.20 | 0.52 | |
| Operating Profit | -0.18 | -0.16 | -0.10 | -0.18 | -0.24 | -0.12 | -0.37 | -0.18 | -0.21 | -0.25 | -0.20 | -0.52 |
| OPM % | ||||||||||||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.58 | 0.50 | 0.43 | 0.37 | 0.32 | 0.28 | 0.24 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 |
| Profit before tax | -0.76 | -0.66 | -0.53 | -0.55 | -0.56 | -0.40 | -0.61 | -0.41 | -0.44 | -0.48 | -0.43 | -0.75 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| -0.76 | -0.66 | -0.54 | -0.55 | -0.56 | -0.40 | -0.61 | -0.40 | -0.44 | -0.48 | -0.42 | -0.74 | |
| EPS in Rs | -0.06 | -0.05 | -0.04 | -0.04 | -0.04 | -0.03 | -0.05 | -0.03 | -0.03 | -0.04 | -0.03 | -0.06 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -5% |
| 3 Years: | -32% |
| TTM: | -76% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 |
| Reserves | -28.35 | -29.01 | -29.55 | -30.10 | -30.66 | -31.06 | -31.67 | -32.08 | -32.51 | -32.99 | -33.41 | -34.15 |
| 4.49 | 4.50 | 5.15 | 6.45 | 6.48 | 6.48 | 6.49 | 6.49 | 6.55 | 6.77 | 6.83 | 6.89 | |
| 8.59 | 9.67 | 9.93 | 10.05 | 10.13 | 10.13 | 10.36 | 10.60 | 10.73 | 10.84 | 10.92 | 11.31 | |
| Total Liabilities | 11.15 | 11.58 | 11.95 | 12.82 | 12.37 | 11.97 | 11.60 | 11.43 | 11.19 | 11.04 | 10.76 | 10.47 |
| 3.66 | 3.16 | 2.73 | 2.36 | 2.04 | 1.76 | 1.52 | 1.30 | 1.07 | 0.85 | 0.62 | 0.40 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 7.49 | 8.42 | 9.22 | 10.46 | 10.33 | 10.21 | 10.08 | 10.13 | 10.12 | 10.19 | 10.14 | 10.07 | |
| Total Assets | 11.15 | 11.58 | 11.95 | 12.82 | 12.37 | 11.97 | 11.60 | 11.43 | 11.19 | 11.04 | 10.76 | 10.47 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.03 | -0.08 | -0.51 | -1.32 | -0.19 | -0.11 | -0.15 | -0.03 | -0.07 | -0.14 | -0.12 | ||
| 0.00 | 0.00 | 0.13 | -0.07 | 0.02 | 0.06 | 0.15 | 0.01 | 0.04 | -0.05 | 0.07 | ||
| 0.00 | 0.00 | 0.65 | 1.30 | 0.03 | 0.00 | 0.01 | 0.00 | 0.06 | 0.22 | 0.06 | ||
| Net Cash Flow | -0.03 | -0.08 | 0.27 | -0.09 | -0.15 | -0.06 | 0.01 | -0.01 | 0.02 | 0.03 | 0.01 | |
| Free Cash Flow | -0.03 | -0.08 | -0.51 | -1.32 | -0.19 | -0.11 | -0.15 | -0.03 | -0.07 | -0.14 | -0.12 | |
| CFO/OP | 17% | 50% | 510% | 733% | 79% | 92% | 41% | 17% | 33% | 56% | 60% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | ||||||||||||
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | ||||||||||||
| Working Capital Days | ||||||||||||
| ROCE % | -25.94% | -29.53% | -26.97% | -22.96% | -22.36% | -19.61% | -39.61% | -39.61% | -68.22% | -145.45% | -2,150.00% |
Documents
Announcements
-
AUDITED FINANCIAL RESULT FOR THE QUARTER AND YEAR ENDED ON 31.03.2026
30 May - Audited FY26 results approved; Q4 loss 25.82 lakh, annual loss 74.25 lakh, unmodified audit opinion.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
30 May - Annual Secretarial Compliance Report for FY 2025-26 submitted, issued by Sumit Bajaj & Associates.
-
Appointment Of Chief Financial Officer (CFO)
29 May - Mr. Kashi Nath Jha appointed CFO and KMP effective 29 May 2026.
-
Board Meeting Intimation for Consider And Approve Audited Financial Results (Standalone) For The Quarter And Year Ended March 31, 2026.
19 May - Board meeting on 30 May 2026 to approve audited standalone results for quarter and year ended 31 March 2026.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
21 Apr - Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended on 31.03.2026
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse